Research makes important discovery about pulmonary sequelae after COVID-19 infection
A collaborative study sought to identify the sequelae associated with long-term pulmonary dysfunction (L-PDD) in patients with COVID-19.
Jan 4, 2024
0
31
A collaborative study sought to identify the sequelae associated with long-term pulmonary dysfunction (L-PDD) in patients with COVID-19.
Jan 4, 2024
0
31
Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less ...
Jan 3, 2024
0
11
The average cost of providing care to hospitalized COVID-19 patients increased five times faster than the rate of medical inflation during the first two years of the pandemic, at least partly because of the application of ...
Jan 3, 2024
0
46
Researchers at the Icahn School of Medicine at Mount Sinai have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric ...
Jan 2, 2024
0
48
The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article ...
Dec 20, 2023
0
31
Researchers have long linked physical fitness to higher academic performance.
Dec 19, 2023
0
1
Climate change is our planet's most immediate existential threat, and will likely only worsen for the foreseeable future.
Dec 13, 2023
0
0
The golden road to pharmaceutical riches can quickly become a rocky wilderness trail. Chemical compounds that hit a target in the lab often fall short in human studies.
Dec 13, 2023
0
18
In celebrating its 75th anniversary, the World Health Organization has recently called for a renewed drive for health equity—that is, the opportunity for everyone to achieve an optimal health status.
Dec 11, 2023
0
0
Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to target CD19, show a 100% complete response (CR) rate at the higher dose levels studied in the trial, ...
Dec 11, 2023
0
0